Mostafa Kamal, CEO, Magellan Rx Management at MAGELLAN HEALTH INC (MGLN), sold 4,380 shares at $80.96 ($355K) on 2017-09-05, disclosed to the SEC on 2017-09-08.
Open-market sale of $355k MGLN by CEO, Magellan Rx Management. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.96 | 1,157 | $94K | 26.4% |
| 2 | $80.96 | 1,157 | $94K | 26.4% |
| 3 | $81.19 | 1,033 | $84K | 23.6% |
| 4 | $81.19 | 1,033 | $84K | 23.6% |
| Total | $81.07 avg | 4,380 | $355K | 100% |
| Filing → |
| MGLN | SELL | 2020-11-12 | $979K | — | Filing → |
| MGLN | SELL | 2020-11-06 | $1.1M | — | Filing → |
| MGLN | SELL | 2020-10-20 | $15K | — | Filing → |